Medicare Enrolled
Dr. Jonathan Dunn, M.D.
Cardiovascular Disease · South Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dunn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dunn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dunn
Dr. Jonathan Dunn is a cardiovascular disease specialist in South Miami, FL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Dunn performed 3,081 Medicare services across 1,584 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dunn received a total of $7,268 from 37 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dunn is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 39% volume in FL
$7,268 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 136855 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗3,081
Medicare services
Top 39% in FL for cardiovascular disease
1,584
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~237 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
900 | $0 | $1 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
435 | $11 | $32 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
316 | $93 | $270 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
258 | $69 | $195 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
185 | $147 | $424 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
169 | $69 | $170 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
106 | $118 | $360 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
90 | $351 | $500 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
88 | $41 | $110 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
78 | $39 | $105 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
77 | $50 | $150 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
45 | $361 | $960 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
44 | $149 | $416 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
40 | $52 | $160 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $102 | $220 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
34 | $148 | $430 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
24 | $22 | $57 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
24 | $684 | $1,860 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $68 | $158 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
22 | $74 | $196 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
18 | $72 | $224 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
16 | $6 | $17 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
16 | $2 | $10 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $86 | $240 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
13 | $6 | $9 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
11 | $147 | $405 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.5% high complexity
42.6% medium
50.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,268
Total received (2018-2024)
Avg $1,038/year across 7 years
Top 30% in FL for cardiovascular disease
37
Companies
282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,169 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,223
2023
$1,738
2022
$1,477
2021
$656
2020
$674
2019
$782
2018
$719
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$659
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$640
Janssen Pharmaceuticals, Inc
$624
Boston Scientific Corporation
$552
Abbott Laboratories
$543
Amarin Pharma Inc.
$464
AstraZeneca Pharmaceuticals LP
$424
PFIZER INC.
$423
E.R. Squibb & Sons, L.L.C.
$297
Novo Nordisk Inc
$288
Medtronic, Inc.
$265
Novartis Pharmaceuticals Corporation
$233
Astellas Pharma US Inc
$172
Shockwave Medical, Inc
$163
Medtronic Vascular, Inc.
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$126
HEARTFLOW, INC.
$118
Kiniksa Pharmaceuticals, Ltd.
$114
Kiniksa Pharmaceuticals International, plc
$108
SANOFI-AVENTIS U.S. LLC
$108
HeartFlow, Inc.
$96
Impulse Dynamics (USA) Inc.
$86
ATRICURE, INC.
$73
Bayer HealthCare Pharmaceuticals Inc.
$72
Lilly USA, LLC
$68
Alnylam Pharmaceuticals Inc.
$51
Regeneron Healthcare Solutions, Inc.
$49
Akcea Therapeutics, Inc.
$46
ARBOR PHARMACEUTICALS, INC.
$41
Lexicon Pharmaceuticals, Inc.
$38
Merck Sharp & Dohme LLC
$33
Kestra Medical Technology Services, Inc.
$26
Arbor Pharmaceuticals, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$24
Kowa Pharmaceuticals America, Inc.
$23
Lantheus Medical Imaging, Inc.
$19
CVRx, Inc.
$18
Top 3 companies account for 26.5% of total payments
Associated products mentioned in payments ›
AZURE XT DR MRI SURESCAN · Arcalyst · Assure WCD · BRILINTA · Barostim Neo System · CAMZYOS · CLARIA MRI QUAD CRT-D SURESCAN · CardioMEMS HF System · Corlanor · Definity · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · Ensite Cardiac Mapping System · FARXIGA · FFRct · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LIVALO · LifeVest · MICRA · MITRACLIP · MOUNJARO · MULTAQ · Micra · Mitra Clip system · MitraClip System · ONPATTRO · OPTIMIZER · Optimizer · Ozempic · PRALUENT · RESONATE · RYBELSUS · Repatha · Rybelsus · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · TEGSEDI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN FLX · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $236 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
340
Per 100K population
12.7
County median income
$68,694
Nearest hospital
SOUTH MIAMI HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dunn is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dunn experienced with adenosine injection, 1 mg?
Based on Medicare claims data, Dr. Dunn performed 900 adenosine injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dunn receive payments from pharmaceutical companies?
Yes. Dr. Dunn received a total of $7,268 from 37 companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dunn's costs compare to other cardiologists in South Miami?
Dr. Dunn's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dunn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in South Miami
Browse cardiologists in South Miami ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in FL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in FL
Which FL cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology